Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
C-X-C motif chemokine ligand 12 (CXCL12), also known as stromal cell-derived factor 1 (SDF-1), is a homeostatic chemokine that plays a critical role in leukocyte trafficking, hematopoiesis, and organogenesis (UniProt P48061). The heparan-sulfate (HS) binding site of CXCL12 is a specific basic cluster of amino acids, primarily Lys24, His25, and Lys27, that allows the chemokine to interact with glycosaminoglycans (GAGs) on the cell surface and in the extracellular matrix (Sadir et al., 2001, JBC). This interaction is essential for the formation of stable chemokine gradients, which guide the migration of cells expressing the CXCR4 or ACKR3 receptors (Proudfoot et al., 2003, Science). By binding to HS, CXCL12 is also protected from proteolytic degradation, thereby increasing its local concentration and bioactivity (Valenzuela-Fernandez et al., 2002, JBC). In pathological states such as cancer, the CXCL12-HS interaction facilitates tumor cell migration, metastasis, and the recruitment of immunosuppressive cells to the tumor microenvironment (Zlotnik et al., 2011, Immunity). Therapeutic strategies targeting this specific site, such as the Spiegelmer olaptesed pegol (NOX-A12), aim to neutralize CXCL12 and disrupt its attachment to the extracellular matrix, thereby mobilizing cancer cells or stem cells into the peripheral blood (Hoellenriegel et al., 2014, Blood). Targeting the HS-binding site offers a way to modulate chemokine activity without directly blocking the G protein-coupled receptors, potentially offering a different safety and efficacy profile compared to receptor antagonists.
Neutralization of the chemokine by preventing its interaction with cell-surface glycosaminoglycans and its receptors, leading to the mobilization of cells from their niches into the peripheral blood.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on C-X-C motif chemokine ligand 12 heparan-sulfate binding site (CXCL12-HS binding site).